First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease
<a href="https://pixabay.com/users/Free-Photos/">Free-Photos</a> / Pixabay

First Patient Enrolled in Phase 3 Trial for Autosomal Dominant Polycystic Kidney Disease

According to a story from globenewswire.com, the biopharmaceutical company Reata Pharmaceuticals, Inc. has recently announced that the company has officially enrolled its first patient in its phase 3 clinical trial.…

Continue Reading
ICYMI: More Steps Required for Experimental ADPKD Drug in Order to Obtain Orphan Designation
<a href="https://pixabay.com/users/TeroVesalainen/">TeroVesalainen</a> / Pixabay

ICYMI: More Steps Required for Experimental ADPKD Drug in Order to Obtain Orphan Designation

According to a story from thenewsreports.com, the biopharmaceutical company XORTX Therapeutics, Inc., recently announced that the company and its partner Cato Clinical Research have received correspondence from the US Food…

Continue Reading
Close Menu